Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about NOVARTIS AG
08/03NOVARTIS : Kymriah meets endpoint in follicular lymphoma trial
RE
08/03NOVARTIS : gets European approval for psoriasis drug Cosentyx
RE
07/30NOVARTIS : receives Piqray approval in Europe the first and only targeted medici..
AQ
07/29NOVARTIS : receives Piqray® approval in Europe – the first and only target..
PU
07/28NOVARTIS : New Novartis analysis shows wet AMD patients achieved sustained fluid..
AQ
07/28NOVARTIS AG : Morgan Stanley reiterates its Neutral rating
MD
07/27NOVARTIS : Adakveo receives positive CHMP opinion for the prevention of recurren..
AQ
07/27NOVARTIS : Sandoz, Austrian Government to Invest EUR150 Million in Antibiotics P..
DJ
07/27NOVARTIS : Austria team up to support Tyrol antibiotics plant
RE
07/27NOVARTIS : New Novartis analysis shows wet AMD patients achieved sustained fluid..
PU
07/24NOVARTIS : sickle cell drug Adakveo put on path to EU approval
RE
07/23NOVARTIS : announces Phase III study of Jakavi® in chronic graft-versus-host dis..
PU
07/23Publicis beats dire market expectations amid worldwide ad freefall
RE
07/22NOVARTIS AG : HSBC reiterates its Neutral rating
MD
07/22NOVARTIS AG : Gets a Neutral rating from Credit Suisse
MD
More most relevant news
All news about NOVARTIS AG
08/03NOVARTIS : Kymriah meets endpoint in follicular lymphoma trial
RE
08/03NOVARTIS : gets European approval for psoriasis drug Cosentyx
RE
07/31China to add 56 drugs to price-slashing bulk-buy programme
RE
07/30NOVARTIS : receives Piqray approval in Europe the first and only targeted medici..
AQ
07/29China to add 56 drugs to price-slashing bulk-buy programme
RE
07/29NOVARTIS : receives Piqray® approval in Europe – the first and only target..
PU
07/28NOVARTIS : New Novartis analysis shows wet AMD patients achieved sustained fluid..
AQ
07/28NOVARTIS AG : Morgan Stanley reiterates its Neutral rating
MD
07/27NOVARTIS : Adakveo receives positive CHMP opinion for the prevention of recurren..
AQ
07/27NOVARTIS : Sandoz, Austrian Government to Invest EUR150 Million in Antibiotics P..
DJ
More news
News in other languages on NOVARTIS AG
12:16pBourse Zurich: retour de flamme après l'envolée de la veille
09:20aDPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 04.08.2020 - 15.15 Uhr
05:31aBourse Zurich: le SMI creuse ses pertes à l'approche de la mi-journée
03:32aBourse Zurich: le SMI en repli après une ouverture en hausse ténue
03:08aNOVARTIS : données positives dans le lymphome folliculaire
01:41aNovartis erzielt mit Kymriah Ziele in Phase-II bei Lymphom-Krebs
01:38aNovartis revendique un pas vers une 3e indication pour sa thérapie cellulaire
08/03NOVARTIS : Kymriah meets endpoint in follicular lymphoma trial
08/03Bourse Zurich: début de semaine en fanfare, le SMI au-dessus des 10'200 point..
08/03Aktien Schweiz Schluss: Nach guten Konjunkturdaten auf breiter Front fest
Analyst Recommendations on NOVARTIS AG
07/28NOVARTIS AG : Morgan Stanley reiterates its Neutral rating
MD
07/22NOVARTIS AG : HSBC reiterates its Neutral rating
MD
07/22NOVARTIS AG : Gets a Neutral rating from Credit Suisse
MD
07/22NOVARTIS AG : Goldman Sachs reaffirms its Buy rating
MD
07/21NOVARTIS AG : Morgan Stanley gives a Neutral rating
MD
More recommendations
Press releases
07/30NOVARTIS : receives Piqray approval in Europe the first and only targeted medici..
AQ
07/29NOVARTIS : receives Piqray® approval in Europe – the first and only target..
PU
07/28NOVARTIS : New Novartis analysis shows wet AMD patients achieved sustained fluid..
AQ
07/27NOVARTIS : Adakveo receives positive CHMP opinion for the prevention of recurren..
AQ
07/27NOVARTIS : New Novartis analysis shows wet AMD patients achieved sustained fluid..
PU
More press releases
Upcoming event on NOVARTIS AG